First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetes Mellitus - Type 2
- Healthy Volunteers
- Obesity
- Overweight
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Part 1: Single ascending dose Part 2: Multiple ascending doseMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Sponsor staff involved in the clinical trial is masked according to company standard procedures.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 64 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04259801
- Collaborators
- Not Provided
- Investigators
- Study Director: Clinical Reporting Anchor & Disclosure (1452) Novo Nordisk A/S